Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Amgen Inc (AMGN)

2014-04-18@09:49:46 ET
Kyowa Hakko Kirin to terminate licensing agreement with Amgen (DTM)

2014-04-17@21:53:34 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-04-17@21:18:17 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-04-17@20:40:24 ET
Amgen Inc.Corporate Event Announcement Notice (WSH)

2014-04-17@16:05:00 ET
Amgen Announces Webcast of 2014 First Quarter Financial Results (PRN)

2014-04-17@12:15:30 ET
Amgen (AMGN) Showing Resistance Near $117.68 (FBM)

2014-04-17@12:01:23 ET
Amgen Crosses Above its 10-day MA (AMGN) (F78)

2014-04-17@00:37:34 ET
U.S. Cardiologists Indicate that Servier's Ivabradine is Poised to Become the Clinical Gold-Standard in the Treatment of Chronic Heart Failure (CLM)

2014-04-16@11:00:42 ET
Google, Disney, Paramount Execs Join Pepperdine University's Talent Management Symposium, April 25 (BIZ)

2014-04-16@09:44:18 ET
Amgen (AMGN) Showing Bearish Technicals With Resistance At $118.72 (FBM)

2014-04-15@14:22:59 ET
Amgen (AMGN) Showing Resistance Near $116.69 (FBM)

2014-04-15@03:27:15 ET
Global Malignant Glioma Clinical Trials Review 2014 (MTO)

2014-04-14@16:08:58 ET
Amgen (AMGN) Trading Near $117.50 Resistance Level (FBM)

2014-04-14@13:00:00 ET
U.S. Cardiologists Indicate that Servier's Ivabradine is Set to Become the Clinical Gold-Standard in the Treatment of Chronic Heart Failure (PRN)

2014-04-14@06:05:24 ET
Global Biosimilars (Recombinant Non-Glycosylated & Recombinant Glycosylated Proteins & Recombinant Peptides) Market 2013-2018 (MTO)

2014-04-11@08:00:00 ET
Kite Pharma Expands Company's Board of Directors with the Appointment of Jonathan M. Peacock (PRN)

2014-04-11@04:27:32 ET
Global Monoclonal Antibodies Market in Colorectal Cancer 2013-2019 (MTO)

2014-04-11@03:58:51 ET
Global Prostate Cancer Therapeutics Market 2013-2019 (MTO)

2014-04-10@16:54:03 ET
Amgen Set to Possibly Rebound After Yesterday's Selloff of 4.91% (PSM)